Prestige Consumer Healthcare

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Retrieved on: 
Wednesday, April 3, 2024
Aircraft, EST, Culture, Shipyard, Motion sickness, Prestige Consumer Healthcare, History, News, Life, Nausea, Exhibition, Invention, Collection

TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine® .

Key Points: 
  • TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine® .
  • Dramamine and barf bags have been fighting the good fight against nausea together, but the barf bag can make way for a purpose that goes way beyond catching upchucks.
  • Each bag in its repurposed form will be available for purchase for $5, and bundles including a barf bag and Dramamine product will be $10 while supplies last.
  • Consumers can pay their tributes to the barf bag’s cultural impact and secure their piece of barf bag history by visiting TheLastBarfBag.com .

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Retrieved on: 
Wednesday, April 3, 2024
Aircraft, EST, Culture, Shipyard, Motion sickness, NBC, Prestige Consumer Healthcare, History, News, Life, Nausea, Exhibition, Invention, Collection

TARRYTOWN, N.Y., April 3, 2024 /PRNewswire/ -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief, but as Dramamine has risen in popularity, the use of barf bags has sadly diminished. To commemorate the joint anniversary, Dramamine® is breathing new life – not barf – into the paper product with a mission to save its fellow partner in puke.

Key Points: 
  • The documentary short film, The Last Barf Bag: A Tribute to a Cultural Icon , explores the cultural impact of a humble but crucially useful American invention.
  • Dramamine and barf bags have been fighting the good fight against nausea together, but the barf bag can make way for a purpose that goes way beyond catching upchucks.
  • "I use a lot of unorthodox materials in my work, but a barf bag is a first!
  • Consumers can pay their tributes to the barf bag's cultural impact and secure their piece of barf bag history by visiting TheLastBarfBag.com .

The Shipyard Taps Ad Legend Nigel Carr to Serve as Chief Strategy Officer

Retrieved on: 
Friday, February 23, 2024
Shipyard, TBWA\Chiat\Day, Shipyard Brewing Company, Growth, Prestige Consumer Healthcare, Empathy, Partner, Engineering, San Francisco Ballet, Partnership

COLUMBUS, Ohio, Feb. 23, 2024 /PRNewswire/ -- The Shipyard, one of the nation's fastest growing independent advertising agencies, has hired Nigel Carr as Chief Strategy Officer. Recognized for pioneering the strategic planning discipline at Chiat/Day, and kirshenbaum, bond & partners, Carr joins from Tombras, where he served as Chief Strategy Officer for eight years and helped triple agency revenue.

Key Points: 
  • Former Chiat/Day exec joins from Tombras, where he helped triple revenue in 8 years
    COLUMBUS, Ohio, Feb. 23, 2024 /PRNewswire/ -- The Shipyard , one of the nation's fastest growing independent advertising agencies, has hired Nigel Carr as Chief Strategy Officer.
  • Recognized for pioneering the strategic planning discipline at Chiat/Day, and kirshenbaum, bond & partners, Carr joins from Tombras, where he served as Chief Strategy Officer for eight years and helped triple agency revenue.
  • Carr will report to CEO Rick Milenthal and lead strategy, brand planning and insights for the agency.
  • Says Carr: "I'm thrilled to be joining the talented team at The Shipyard, whose superpower is 'Engineering Brand Love.'

Boudreaux's® Butt Barrier® Ointment Awarded 2024 Product of the Year

Retrieved on: 
Friday, February 9, 2024
Trust, Pediatrics, Skin, Associate, Irritation, Safety, Topical medication, Kantar, Parent, Prestige Consumer Healthcare, Butt, Dermatitis, Petroleum jelly

TARRYTOWN, N.Y., Feb. 9, 2024 /PRNewswire/ -- Boudreaux's Butt Paste's Butt Barrier® Ointment has been honored as a recipient of the prestigious 2024 Product of the Year USA Award, recognized as the top product in the baby care category based on a survey of 40,000 people by Kantar. The Product of the Year USA Award is one of the most respected honors in the consumer goods industry, celebrating excellence in product innovation and quality. Boudreaux's Butt Barrier® Ointment stood out among a competitive field of products, showcasing its effectiveness in preventing diaper rash while maintaining the highest standards of safety and reliability.

Key Points: 
  • TARRYTOWN, N.Y., Feb. 9, 2024 /PRNewswire/ -- Boudreaux's Butt Paste's Butt Barrier® Ointment has been honored as a recipient of the prestigious 2024 Product of the Year USA Award, recognized as the top product in the baby care category based on a survey of 40,000 people by Kantar.
  • Boudreaux's Butt Barrier® Ointment stood out among a competitive field of products, showcasing its effectiveness in preventing diaper rash while maintaining the highest standards of safety and reliability.
  • Developed with the utmost care and expertise by Boudreaux's Butt Paste's team of experts, Boudreaux's Butt Barrier® Ointment offers a unique blend of ingredients designed to create a protective barrier against wetness and irritation.
  • The Butt Barrier® Ointment is clinically tested, hypoallergenic, fragrance free and has been accepted by the National Eczema Association.

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, February 8, 2024
EPS, Growth, PBH, International, Cough, Clear, Analgesic, Marketing, Prestige Consumer Healthcare, OTC, Eye, Gastrointestinal tract, Health care, Share repurchase, Cold

Third Fiscal Quarter Ended December 31, 2023

Key Points: 
  • Third Fiscal Quarter Ended December 31, 2023
    Reported revenues in the third quarter of fiscal 2024 of $282.7 million compared to a $275.5 million in the third quarter of fiscal 2023.
  • Diluted earnings per share of $1.06 for the third quarter of fiscal 2024 increased 2.2% versus $1.04 in the prior year comparable period.
  • Non-GAAP free cash flow in the third quarter of fiscal 2024 was $69.5 million, compared to $53.1 million in the prior year third quarter.
  • International OTC Healthcare: Fiscal third quarter 2024 segment revenues were $46.2 million, compared to $38.6 million reported in the prior year comparable period.

Levi Strauss & Co. Appoints David Marberger to Board of Directors

Retrieved on: 
Tuesday, January 9, 2024
Retail, Textiles, Manufacturing, Fashion, Campbell Soup Company, Levi Strauss & Co., Conagra Brands, Accounting, Tastykake, CFO, History, University, LEVI, Godiva Chocolatier, Information technology, Longevity, University of Pennsylvania, CAG, Prestige Consumer Healthcare, Levi Strauss, Growth, Management

(NYSE: LEVI) announced today that its board of directors has appointed David Marberger as a member of the board and to serve on the board’s Audit Committee, effective immediately.

Key Points: 
  • (NYSE: LEVI) announced today that its board of directors has appointed David Marberger as a member of the board and to serve on the board’s Audit Committee, effective immediately.
  • With more than 30 years of finance and leadership experience, Marberger currently serves as the executive vice president and chief financial officer for Conagra Brands, Inc. (NYSE: CAG).
  • “With a distinguished career spanning over three decades, David brings a wealth of experience working with prominent global brands, making him an ideal addition to the LS&Co.
  • “I am honored to join the board at Levi Strauss & Co., a company I’ve long admired for its rich history and longevity as a globally recognized iconic brand,” said Marberger.

Confronting "Tripledemic," Americans Are Concerned About Cough Syrup Effectiveness and Formulas with Hidden Sugars

Retrieved on: 
Monday, December 18, 2023
Holiday, Pharmacist, American Diabetes Association, COVID-19, Prestige Consumer Healthcare, Research, Diabetes, Prediabetes, RSV, Face, Travel, Blood pressure, Pharmaceutical industry, Dietary supplement, Amazon

TARRYTOWN, N.Y., Dec. 18, 2023 /PRNewswire/ -- Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, unveils new data revealing consumers' realities and worries as they navigate the rising threat of a "tripledemic" — flu, RSV (respiratory syncytial virus) and COVID-19 — coinciding with the arrival of cold season.

Key Points: 
  • Consumers are also navigating a cold and flu season that is extending, with 37% getting sick earlier and 43% staying sick for longer periods than ever before.
  • "As the trusted brand for sugar-free cold and cough syrup, Diabetic Tussin can do just that.
  • Over 71% of people get sick once or twice during cold and flu season, with 14% getting sick three times.
  • To learn more about Diabetic Tussin, visit www.diabetictussin.com or check out the brand in Dollar General stores nationwide and on Amazon.

Leadership transition in Avon International

Retrieved on: 
Thursday, November 30, 2023
P&G, Prestige Consumer Healthcare, WBA, Woman, NYSE, Walgreens Boots Alliance, Organization, Breast cancer, Carlucci, World government, BSR, Kristof, Cosmetics, Mentorship, Global Brands Group, Partnership, R, Growth, Beauty, Management, Natura & Co

SÃO PAULO, Nov. 30, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces Kristof Neirynck, currently the Global Chief Marketing Officer and Managing Director for Western Europe, as the new CEO of Avon. After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor.

Key Points: 
  • After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor.
  • Under Angela's leadership, Avon initiated a successful turnaround strategy, streamlining its operating model and radically simplifying its portfolio.
  • As Global Chief Marketing Officer for Avon for the past two years, he drove a complete brand relaunch and achieved significant gross margin improvement.
  • Before joining Avon, Kristof served as the Chief Marketing Officer for Global Brands at Walgreens Boots Alliance (WBA).

Leadership transition in Avon International

Retrieved on: 
Thursday, November 30, 2023
P&G, Prestige Consumer Healthcare, WBA, Woman, NYSE, Walgreens Boots Alliance, Organization, Breast cancer, Carlucci, World government, BSR, Kristof, Cosmetics, Mentorship, Global Brands Group, Partnership, R, Growth, Beauty, Management, Natura & Co

SÃO PAULO, Nov. 30, 2023 /PRNewswire/ -- Natura &Co (NYSE – NTCO; B3 – NTCO3) announces Kristof Neirynck, currently the Global Chief Marketing Officer and Managing Director for Western Europe, as the new CEO of Avon. After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor.

Key Points: 
  • After a landmark 25 years with the company, Angela Cretu will continue to support and contribute to the Avon business, as an advisor.
  • Under Angela's leadership, Avon initiated a successful turnaround strategy, streamlining its operating model and radically simplifying its portfolio.
  • As Global Chief Marketing Officer for Avon for the past two years, he drove a complete brand relaunch and achieved significant gross margin improvement.
  • Before joining Avon, Kristof served as the Chief Marketing Officer for Global Brands at Walgreens Boots Alliance (WBA).

Diabetic Tussin Reintroduces Sugar-Free Cold and Cough Solution for People with Diabetes

Retrieved on: 
Wednesday, November 29, 2023
Cough, RSV, National Diabetes Education Program, Congestion, Risk, Better Choice Parking, Prestige Consumer Healthcare, American Diabetes Association, Fructose, Sorbitol, Mucus, COVID-19, Dollar, Blood, Diabetes, Prediabetes, Sodium, Pharmaceutical industry, Amazon

TARRYTOWN, N.Y., Nov. 29, 2023 /PRNewswire/ -- Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves. This restock brings with it the Better Choices for Life mark from the American Diabetes Association® (ADA). This over-the-counter cold and cough solution returns just as the threat of a 'tripledemic' — when cases of COVID-19, flu, and RSV surge at the same time—looms over American households.

Key Points: 
  • TARRYTOWN, N.Y., Nov. 29, 2023 /PRNewswire/ -- Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves.
  • This over-the-counter cold and cough solution returns just as the threat of a 'tripledemic' — when cases of COVID-19, flu, and RSV surge at the same time—looms over American households.
  • "Diabetic Tussin is an essential over-the-counter cold and cough solution for millions of Americans concerned about ingredients in other products that can raise blood sugar levels.
  • Made with the strongest sugar-free formula on the market, Diabetic Tussin Max allows consumers to effectively manage their cough and cold symptoms with the right ingredients.